Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19-Why Should Screening for Cardiovascular Diseases Be Performed? Reply to Vankrunkelsven, P. Tendentious Paper-Titles and Wrong Conclusions Lead to Fear in the Population and Medical Overconsumption. Comment on "Luchian et al. Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19. Diagnostics 2022, 12, 57"

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
42 Downloads (Pure)

Abstract

We have read with interest the comment by Vankrunkelsven P. [...].

Original languageEnglish
Article number1837
Pages (from-to)1-3
Number of pages3
JournalDiagnostics (Basel, Switzerland)
Volume12
Issue number8
DOIs
Publication statusPublished - Aug 2022

Bibliographical note

Funding Information:
This work was supported by grant from the research center for Nanocatalysis funded by the Ministry of Science and Technology of Republic of Korea.

Copyright:
Copyright 2023 Elsevier B.V., All rights reserved.

Keywords

  • Subclinical Myocardial Dysfunction
  • Persistent Dyspnea
  • COVID-19

Fingerprint

Dive into the research topics of 'Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19-Why Should Screening for Cardiovascular Diseases Be Performed? Reply to Vankrunkelsven, P. Tendentious Paper-Titles and Wrong Conclusions Lead to Fear in the Population and Medical Overconsumption. Comment on "Luchian et al. Subclinical Myocardial Dysfunction in Patients with Persistent Dyspnea One Year after COVID-19. Diagnostics 2022, 12, 57"'. Together they form a unique fingerprint.

Cite this